Abstract-Effects of recombinant human epidermal growth factor (hEGF) on survival of primary cultured neurons from various regions of fetal rat brain were compared with those of recombinant human basic fibroblast growth factor (hbFGF). Addition of hEGF (0.001-10 ng/ml) in chemically-defined serum-free medium enhanced significantly the survival of cultured neurons from all regions tested, i.e., cerebral cortex, septum, striatum, hippocampus, thalamus, colliculus and cerebellum. How ever, its effective concentration differed considerably with the regions. The most sensitive regions were the colliculus and cerebellum (minimum effective concentra tion, 0.001 ng/ml), while the least sensitive was the cerebral cortex (minimum effective concentration, 10 ng/ml). Maximum numbers of surviving neurons in the presence of hEGF were smaller than those of hbFGF in all regions. Maximum effects of hEGF compared with those of hbFGF was greatest in the striatum and smallest in the cerebral cortex. These results suggest that hEGF may exert neuro trophic effects for limited populations of brain neurons. When hEGF (1-10 ng/ml) and hbFGF (0.01-10 ng/ml) were added together, hEGF increased the effects of a lower concentration of hbFGF in an additive manner, but the maximum effects of hbFGF were not potentiated by hEGF in all regions tested. Therefore, mechanisms underlying the effects of hEGF very probably overlap with those of hbFGF.
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Epidermal growth factor (EGF) is a single chain polypeptide composed of 53 amino acids (1, 2), which was originally isolated from male mouse submaxillary glands (3, 4) . Its mitogenic activities for a variety of cell types are well-known (5, 6) . However, it has been recently reported that EGF enhances the survival and process outgrowth of primary cultured cortical, striatal (7) and cerebellar (8) In the present study, we investigated the effects of recombinant human EGF (hEGF) on the survival of primary cultured neurons from various brain regions as a first step for iden tification of neurons responsive to hEGF. Furthermore, the effects of hEGF were com pared with those of recombinant human bFGF (hbFGF).
Neurotrophic effects of hbFGF have been already confirmed in our laboratory (9) .
Materials and Methods
Procedures for cell cultures and determina tion of neuronal survival were the same as described in our previous paper (9) . Briefly, the desired region of the brain was isolated from embryonic day 17-18 Wistar rats and dissociated by incubation with 0.25% trypsin and 0.01% DNase I, followed by pipetting. The brain regions tested in the present study were the cerebral cortex, septum, striatum, hippocampus, thalamus, colliculus and cerebellum. The cell suspensions were plated in poly-L-lysine-coated plastic 48-well plates at a density of 100,000 cells/cm2 with modified Eagle's medium supplemented with 10% fetal bovine serum. They were cultured at 37'C for 24 hr in a humidified 5% C02-95% air atmosphere, and the medium was changed to serum-free DF/TIP medium with or without the desired concentrations of drugs. After 3 days, the cultures were fixed with 4% para formaldehyde.
The neurons were specifically stained by using an avidin-biotin-peroxidase complex method with monoclonal antibodies to neurofilaments, and the number of sur viving neurons in each well was counted under a microscope. In the present cultures, more than 90% of the cells were labeled by monoclonal antibodies to neurofilaments and also identified as neurons by their mor phology.
Recombinant hEGF (a generous gift from Wakunaga Pharmaceutical Co., Ltd.) and recombinant hbFGF (a generous gift from Takeda Chemical Industries, Ltd.) were first diluted to a concentration of 10 ug/ml in distilled water supplemented with 1 mg/ml bovine serum albumin (BSA) to prevent non specific binding of the proteins. This small aliquots were stored at -20°C until use. The stored drugs were further diluted to the desired concentrations by DF/TIP medium just before application in the cell cultures. In preliminary experiments, BSA did not signifi cantly influence the survival in concentra tions up to 1 /cg/ml.
All data were expressed as the mean± S.E.M. of n independent observations. Signifi cance of the difference was determined using Student's t-test for unpaired observations.
Results
Addition of hEGF (0.001-10 ng/ml) in creased the survival of cultured neurons from all regions tested. However, the concen tration-dependency was considerably dif ferent among the brain regions (Fig. 1) . The regions most sensitive to hEGF were the col liculus and cerebellum, in which the minimum effective concentration of hEGF was 0.001 ng/ml. On the other hand, the survival of cerebral cortical neurons was not significantly influenced by less than 10 ng/ml hEGF. The number of cells that were not labeled by monoclonal antibodies to neurofilaments was not significantly changed by addition of hEGF (data not shown).
The maximum effects of hEGF (1 or 10 ng/ ml) were compared with those of hEGF (10 ng/ml) in the same cultures (Fig. 2) . Although the maximum numbers of surviving neurons in the presence of hEGF were always smaller than those of hbFGF regardless of regions, the ratio of the maximum effects of hEGF and those of hbFGF differed considerably with regions. Taking the maximum effects of hbFGF (differences between numbers of surviving neurons with and without hbFGF) as 100%, the maximum effects of hEGF (differences between numbers of surviving neurons with and without hEGF) was greatest (46%) in the striatum and smallest (5%) in the cerebral cortex. The percentage maximum effects of hEGF in the other regions were as follows: septum, 26%; hippocampus, 11%, thalamus, 20%; colliculus, 37%; cerebellum, 23%.
Discussion
The present results show that h EG F exerted neurotrophic effects on brain neurons with considerable regional differences. The neurons from the cerebellum and colliculus were most sensitive to hEGF, and the maxi mum effect in comparison with hbFGF was greatest for the neurons from the striatum. Cerebral cortical neurons were least respon sive to hEGF in terms of both sensitivity and maximum effects. The data were expressed as the mean+S.E.M. (n=5).
Asterisks indicate significant differences from the group without drugs (closed columns): *P<0.05. (10) . It is necessary to compare the results in the ex periments with animals of different ages. Thirdly, it is also known that the nature of glia differs with brain regions (1 1 ). However, in the present cultures, influence of non-neu ronal cells including glial cells was restricted by the following respects: 1) fetal brains were used; 2) the cells were plated at a re latively lower density; 3) the culture period was relatively short so that non-neuronal cells did not significantly proliferate. Al though the influence of non-neuronal cells cannot be completely ruled out (12, 13) , the regional differences of the effects of hEGF observed in the present study cannot be ex plained by it solely. Data on the distribution of EGF receptors will provide useful information about the targets of EGF. There are reports in which localization of EGF receptors in the brain was investigated by use of immunohistochemical staining in rats (14) and humans (15) . In adult rat brain, EGF receptor immunoreac tivity was detected selectively in cerebral cortical basket cells and cerebellar Purkinje cells (14) . In human brain, some types of neurons (e.g., cerebral cortical pyramidal cells, hippocampal pyramidal cells, cerebellar Purkinje cells, etc.) contained immunoreac tive EGF receptors (15) . Some discrepancy between these data may be due to different antiserum or preparations used. Anyway, the EGF receptor seems to be characteristically expressed on selective populations of neu rons. The EGF receptor distribution in cul tured neurons from fetal rat brain is unknown.
As reported previously, hbFGF exerts its survival promoting effects throughout the brain without regional differences (9) . Al though the meaning of regional differences is unclear, the effects of hEGF are undoubtedly different from those of hbFGF. The following speculations can be made: 1) hEGF and hbFGF act on entirely different populations of neurons; 2) cellular mechanisms underlying the neurotrophic effects of hEGF and hbFGF are completely different. However, these ideas are rejected by the result that synergism, particularly potentiation, was not observed between the effects of hEGF and hbFGF. Mechanisms underlying the neurotrophic ef fects of hEGF probably overlap with those of hbFGF. Considering the fact that the maxi mum effects of hEGF were smaller than those of hbFGF in all regions, it is likely that hbFGF acts on a wide range of neurons and hEGF acts on limited populations of them. Asterisks indicate significant differences from the group without hEGF (0): *P<0.05.
Morrison et al. (8) reported that EGF was effective in enhancing the survival of cultured cerebellar neurons, but bFGF was ineffective, which is contrary to our results. Our experi ments and theirs are different mainly in the following respects: 1) origin of EGF and bFGF, 2) age of animals used, and 3) the other culture procedures and conditions. They used EGF purified from mouse submaxillary glands and bFGF purified from bovine pitui tary glands. Human EGF will be identical to mouse EGF in terms of both chemical struc tures and biological activities (5) . Further more, neurotrophic effects of hbFGF on brain neurons will be substantially the same as those of bovine bFGF as reported in our pre vious paper (9) . Therefore, the discrepancy cannot be explained by the origin of the peptides. What is more important is the fact that they used postnatal (0-1 -day-old) rats. The rat cerebellum develops dramatically from embryonic day 13 to postnatal day 20 (16) . It is likely that the influence of growth factor(s) on neuronal development or main tenance is changed by developmental stage (17) . To examine this possibility, we are pro ceeding to make a comparative study of the effects of hEGF and hbFGF for neurons from animals of different ages under the same culture conditions. accurately measured in the present cultures. It is necessary to prepare cell cultures of low density in which cell interactions are mini mized.
EGF precursor mRNA is present in the brain, although at a very low level (18) . EGF like material was immunohistochemically de tected in rat brain using three different anti EGF antibodies (19) . Furthermore, EGF was detected in synaptosomes from the cerebral cortex by radioimmunoassay (20) . Immunore active EGF was detected in human cerebro spinal fluid also (21) . However, it has been reported that EGF could not be detected in the brain by using a sensitive immunoassay (22) . These data could not be easily com pared because of the different methods used. Existence of EGF in the brain is controversial.
In conclusion, we demonstrated differential neurotrophic effects of hEGF for neurons from various brain regions. Further investiga tions of several factors involved in the re gional differences (e.g., neuronal subtypes, development, etc.) will provide a new under standing about the regulatory mechanisms of selective neuronal development and main tenance in the brain nervous system.
